Mesenchymal Stem Cells: Clinical Trials

107 trials of Mesenchymal Stem Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 unknown, 34 completed, 7 terminated, 5 recruiting. 68 Phase 2, 61 Phase 1, 6 Early Phase 1, 6 Not applicable, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 268Unknown 32, Completed 22, Terminated 6, Enrolling by invitation 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 161Unknown 28, Completed 21, Terminated 5, Enrolling by invitation 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Early Phase 16Unknown 5, Recruiting 1
Not applicable6Completed 3, Unknown 2, Suspended 1
Phase 35Completed 2, Enrolling by invitation 1, Recruiting 1, Terminated 1

Follow Mesenchymal Stem Cells: new trials by email Literature Review of Mesenchymal Stem Cells trials Research Report on Mesenchymal Stem Cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline - Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic
Phase 1 / Phase 2Not yet recruitingMahidol University402026-09-152026-09-02
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
Mesenchymal Stem Cells, Sodium Hyaluronate Injection - Knee Osteoarthritis
Phase 3RecruitingWuxi Cellular Biopharmaceutical Group Ltd.5202025-02-282025-07-16
Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Mesenchymal Stem Cells, Placebo - Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE)
Phase 1 / Phase 2Enrolling by invitationNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan2002025-02-012025-03-21
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.
Mesenchymal Stem Cells, 0.9 % saline - Androgenetic Alopecia, Androgenetic Alopecia (AGA)
Phase 1 / Phase 2Enrolling by invitationNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan702024-12-252025-01-08
Orthobiologic Treatment for Knee Osteoarthritis
PRP injection, ADSTEM Inj. (Adult human mesenchymal stem cells), Injection - Osteoarthritis Knee
Phase 2 / Phase 3Enrolling by invitationUniversity Hospital of North Norway1602024-09-232026-06-15
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
Mesenchymal Stem Cells, Other: Placebo - Chronic Pancreatitis, Chronic Pain
Early Phase 1RecruitingMedical University of South Carolina482024-07-172026-09-30
Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells
Alofisel, Fat stem cell - Crohn Disease, Anal Fistula
RecruitingNantes University Hospital202024-01-022026-06-24
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Mesenchymal stem cells, Placebo - Chronic Pancreatitis, Chronic Pain
Phase 1RecruitingVA Office of Research and Development402024-01-012026-04-07
Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
mesenchymal stem cells with OCN-19, Mesenchymal stem cells, albumin injection - Diabetes, Type 2 Diabetes
Phase 2RecruitingLu jin ,MD102023-11-062024-12-17
Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction
Mesenchymal stem cells - Chronic Lung Disease, Lung Transplant Rejection
Phase 1UnknownInstituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana122023-09-192024-07-26
Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?
Mesenchymal Stem Cells, Comparative placebo - Safety Issues, Efficacy
Phase 2UnknownCentre Hospitalier Universitaire de Liege502023-06-062024-03-19
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
mesenchymal stem cells, saline - Lung Injury
Phase 1 / Phase 2UnknownCell Energy Life Sciences Group Co. LTD802023-05-102024-05-16
Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection
normal saline, Mesenchymal stem cells - AIDS Virus, Disorder of Immune Reconstitution
Early Phase 1UnknownShandong Qilu Cell Therapy Engineering Technology Co., Ltd202023-04-162023-05-24
Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial
Mesenchymal stem cells, Normal Saline (Placebo) - Diabetic Kidney Disease
Phase 2CompletedNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan782022-12-012025-06-26
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
Mesenchymal stem cells, Saline - Acute Kidney Injury, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownChinese PLA General Hospital802021-12-312021-10-25
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
MSCs, Saline - Multiple Sclerosis, Progressive Multiple Sclerosis
Phase 1 / Phase 2Active not recruitingHaukeland University Hospital182021-08-092026-03-12
Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis
CELLISTEM-OA, Triamcinolone acetonide - Mesenchymal Stem Cells, Knee Osteoarthritis
Phase 1 / Phase 2UnknownFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle302021-06-012021-04-28
Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease
Mesenchymal stem cells - Perianal Fistula Due to Crohn's Disease (Disorder)
Phase 1TerminatedAnthony Lembo62021-04-012026-04-16
MSC for Treatment of cGVHD After Allo-HSCT
Mesenchymal stem cells, Glucocorticoids, cyclosporine - Chronic Graft-versus-host Disease
Phase 2UnknownNanfang Hospital, Southern Medical University1522021-01-102020-12-31
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Mesenchymal Stem Cells, Placebo - Perianal Crohn Disease, Perianal Fistula
Phase 1 / Phase 2TerminatedAnthony Lembo252020-11-192026-04-16

Showing 20 of 107. Sign in to see all of them.

Conditions studied

Graft vs Host Disease (8)  ·  Multiple Sclerosis (6)  ·  Osteoarthritis, Knee (6)  ·  Crohn Disease (5)  ·  Anemia, Aplastic (3)  ·  Bronchiolitis Obliterans Syndrome (3)  ·  Chronic Limb-Threatening Ischemia (3)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 1 (3)  ·  Diabetic Foot (3)  ·  Liver Cirrhosis (3)  ·  Osteoarthritis (3)  ·  Parkinson Disease (3)  ·  Spinal Cord Injuries (3)  ·  COVID-19 (2)

Sponsors

Nanfang Hospital, Southern Medical University (5)  ·  National Institute of Blood and Marrow Transplant (NIBMT), Pakistan (5)  ·  Qingdao University (5)  ·  University of Liege (5)  ·  Anthony Lembo (4)  ·  Guangzhou General Hospital of Guangzhou Military Command (4)  ·  Hebei Medical University (4)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (3)  ·  University Hospital, Toulouse (3)  ·  Chinese PLA General Hospital (2)  ·  Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (2)  ·  Alliancells Bioscience Corporation Limited (1)  ·  Ankara University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)

Countries

China (33)  ·  United States (13)  ·  Belgium (6)  ·  France (6)  ·  Pakistan (6)  ·  Spain (4)  ·  Turkey (Türkiye) (4)  ·  United Kingdom (4)  ·  Belarus (3)  ·  India (3)  ·  Netherlands (3)  ·  Russia (3)  ·  Australia (2)  ·  Canada (2)  ·  Iran (2)

Top investigators

Amy Lightner, MD (4)  ·  Baoyong Yan, Doctor (4)  ·  Yang Xiao, MD (4)  ·  Yves Beguin, MD, PhD (4)  ·  Augustin Ferrant, MD, PhD (2)  ·  Bing Ma, Master (2)  ·  Bojian Sun, Master (2)  ·  Chantal Lechanteur, PhD (2)  ·  Dan Zhao, Master (2)  ·  Etienne Baudoux, MD (2)  ·  Evelyne Willems, MD (2)  ·  Fan Zhang, Bachelor (2)  ·  Igor Volotovski, Prof (2)  ·  Johan Maertens, MD (2)

Results publications

PMID 31072380, PMID 12529557, PMID 15037681, PMID 15199405, PMID 16108461, PMID 17641052, PMID 19172693, PMID 19416339, PMID 19883750, PMID 20109568, PMID 20631189, PMID 22236384, PMID 22242033, PMID 22958838, PMID 23133515, PMID 2323151, PMID 23731760, PMID 23758736, PMID 24100132, PMID 24430407, PMID 24708472, PMID 24876849, PMID 24909743, PMID 25204974, PMID 25593079, PMID 25822648, PMID 25986622, PMID 26006200, PMID 26901787, PMID 26925108, PMID 26971680, PMID 27515308, PMID 27535166, PMID 27632779, PMID 28284916, PMID 28949952, PMID 29016557, PMID 29333165, PMID 29764889, PMID 29769612, PMID 31711513, PMID 31842921, PMID 32813884, PMID 33253391, PMID 33362471, PMID 33783227, PMID 34362453, PMID 34482377, PMID 35078125, PMID 35190406

NIH funding

1UG3DK136705-01 (1), 2014 (1), 2016 (1), I01CX002516 (1)